Loading...
Loading...
Analysts at Oppenheimer initiated coverage on
TRACON Pharmaceuticals Inc.TCON with a Outperform rating.
The target price for TRACON Pharmaceuticals is set to $22.
TRACON Pharmaceuticals' shares climbed 0.10% to close at $10.15 yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
